Verizon Communications Inc. (VZ) was reiterated an ‘Outperform’ by RBC Capital Markets analysts on Tuesday. The broker however, cut its price target on the stock to $56 from $58.
Verizon shares currently have a PEG and forward P/E ratio of 3.57 and 12.49, respectively. Price/sales for the same period is 1.57 while EPS is $4.37. Currently there are 10 analysts that rate VZ stock a ‘Buy’, 23 rate it a ‘Hold’. No analyst rates it a ‘Sell’. VZ stock has a median Street price target of $53.00 with a high target of $58.00.
In the past 52 weeks, shares of New York City-based company have traded between a low of $38.06 and a high of $54.49 and are now at $50.56.
Shares are up 6.38% year-over-year and 12.35% year-to-date.
General Electric (GE) was reiterated as ‘Buy’ with a $34 from $36 price target on Tuesday by Stifel.
GE is currently valued at $286.45 billion. The name has a median Street price target of $34.00 with a high target of $38.00.
Time Warner Inc. (TWX) rating of ‘Outperform’ was reiterated today at Telsey Advisory Group with a price target increase of $91 from $89 (versus a $76.35 previous close).
TWX stock began trading this morning at $76.40 to currently trade 0.39% higher from the prior days close of $76.35. On an intraday basis it has gotten as low as $76.09 and as high as $76.96.
Time Warner shares have advanced 9.06% in the last 4 weeks while advancing 10.12% in the past three months. Over the past 5 trading sessions the stock has gained 1.50%.
TWX stock recently traded at $76.71, a gain of $0.36 over Monday’s closing price. The name has a current market capitalization of $60.61 billion.
As for passive income investors, the New York City-based company pays shareholders $1.61 per share annually in dividends, yielding 2.10%. Five year average dividend yield currently stands at 2.03%.
Mosaic Company (MOS) was reiterated as ‘Outperform’ this morning, but with a price target decrease to $29 from $30 at RBC Capital Markets.
On valuation measures, Mosaic shares are currently priced at 10.23x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s 11.84x earnings multiple. The company’s next year EPS growth estimates stand at 30.90%, compared to the industry growth rates of 14.50%. Mosaic has a t-12 price/sales ratio of 1.12. EPS for the same period registers at 2.78.
The Palo Alto, Calif.-based company has a median analyst price target of $26.25 with a high target of $40.
Mosaic shares are down 35.10% year-over-year.
Needham this morning slashed its price target on the shares to $20 from $53 after FDA advisers voted against backing an experimental Sarepta drug to treat a form of muscular dystrophy.
Sarepta Therapeutics, Inc. (SRPT) stock closed at $14.95 on Monday and is currently trading down $4.03.
In the past 52 weeks, shares of the company have traded between a low of $7.86 and a high of $41.97 and are now trading at $10.92.
Shares are up 9.44% year-over-year ; down 61.25% year-to-date.